CING
NASDAQ · Pharmaceuticals
Cingulate Inc
$7.38
-0.13 (-1.73%)
Open$7.08
Previous Close$7.51
Day High$7.99
Day Low$6.60
52W High$11.89
52W Low$3.20
Volume—
Avg Volume975.9K
Market Cap87.33M
P/E Ratio—
EPS$-5.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+94.9% upside
Current
$7.38
$7.38
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.37M | 8.17M | 9.32M |
| Net Income | 2.92M | 2.10M | 3.15M |
| Profit Margin | 34.9% | 25.8% | 33.8% |
| EBITDA | 4.25M | 3.98M | 4.18M |
| Free Cash Flow | 2.06M | 2.44M | 3.61M |
| Rev Growth | +14.6% | -6.6% | +11.6% |
| Debt/Equity | 0.37 | 0.32 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |